<DOC>
	<DOCNO>NCT01506349</DOCNO>
	<brief_summary>Many patient celiac disease complain neurocognitive symptom mental confusion , grogginess , difficulty concentration forgetfulness exposure gluten . However , little data possible association impair cognitive function gluten intake celiac disease . The investigator predict patient celiac disease , expose gluten , experience neurocognitive symptom confusion , forgetfulness difficulty concentrate . The goal study determine prevalence neurocognitive symptom exposure gluten patient celiac disease characterize nature symptom term duration severity .</brief_summary>
	<brief_title>Assessing Neurocognitive Effects Gluten Exposure</brief_title>
	<detailed_description />
	<mesh_term>Celiac Disease</mesh_term>
	<mesh_term>Neurobehavioral Manifestations</mesh_term>
	<criteria>1 . Male female 2 . 1850 year age 3 . Celiac Disease Group : Positive small intestinal biopsy meet Marsh II III histologic criterion celiac disease least six month since time study entrance well positive IgA antitissue transglutaminase antibody positive IgA/IgG antiDeamidated Gliadin Peptide ( DGP ) normal serum IgA 4 . NonCeliac Gluten Sensitive Group : Negative small intestinal biopsy negative IgA antitissue transglutaminase ( tTG ) negative IgA/IgG antiDeamidated Gliadin Peptide ( DGP ) normal serum IgA , symptomatic response gluten withdrawal 5 . Subject well control celiac disease glutenfree diet least six month prior study enrollment 6 . Subject must provide informed consent , approve Institutional Review Board , agree complete require study visit , blood work neuropsychological test urine pregnancy test ( applicable ) . 7 . Subject agree use appropriate birth control duration study . 1 . Subject food intolerance food allergy ( gluten ) would interfere conduct study ( e.g . corn starch , soy ) . 2 . Subject history severe , acute symptomatic reaction sporadic gluten ingestion 3 . Subject chronic active gastrointestinal disease celiac disease ( e.g . Crohn 's disease , irritable bowel syndrome , autoimmune enteropathy , eosinophilic enteritis ) . 4 . Subject daily symptom concern brain fog mental confusion difficulty concentrating , baseline . 5 . Subject symptomatic neurological psychiatric disease ( ) would interfere conduct study . 6 . Subject corticosteroid immunosuppressive agent past 3 month . 7 . Significant comorbidity determine Principal Investigator 8 . Subject deem inappropriate Principal Investigator . 9 . Subject pregnant breastfeeding time participation . 10 . Subject weigh less 110 pound .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>celiac disease</keyword>
	<keyword>gluten</keyword>
	<keyword>fog</keyword>
	<keyword>attention</keyword>
</DOC>